Repligen Company

Repligen is a biopharmaceutical company developing consumable products for the manufacture of biological drugs.
Technology: Others
Industry: PharmTech
Headquarters: Waltham, Massachusetts, United States
Founded Date: 1981-01-01
Employees Number: 1001-5000
Funding Status: IPO
Total Funding: 918225000
Estimated Revenue: $50M to $100M
Last Funding Type: Post-IPO Equity

Visit Website
investors@repligen.com
http://twitter.com/mAntibody_News
Register and Claim Ownership